Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant antibodies possessing novel effector functions.

T W Love, M S Runge, E Haber

    Methods in Enzymology
    |January 1, 1989
    PubMed
    Summary

    Researchers developed a method to create bifunctional, antibody-targeted proteins. This technique allows complex molecules like antibody-tissue plasminogen activator (t-PA) hybrids to retain function, enabling new therapeutic and investigative tools.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Large-Area Epitaxial Mott Insulating 1T-TaSe<sub>2</sub> Monolayer on GaP(111)B.

    Nano letters·2023
    Same author

    Outcomes of renal replacement therapy in the critically ill with COVID-19.

    Medicina intensiva·2021
    Same author

    Outcomes of renal replacement therapy in the critically ill with COVID-19.

    Medicina intensiva·2021
    Same author

    Use of controlled vignettes in evaluation: does type of response method make a difference?

    Evaluation and program planning·2013
    Same author

    The impact of biotechnology on advances in cardiovascular medicine.

    Trends in cardiovascular medicine·2011
    Same author

    Route of administration-dependent anti-inflammatory effect of liposomal alendronate.

    Journal of controlled release : official journal of the Controlled Release Society·2010

    Area of Science:

    • Biotechnology and Recombinant Protein Engineering
    • Immunology and Antibody Engineering
    • Molecular Biology and Protein Chemistry

    Background:

    • Antibody-targeted proteins offer potential for precise delivery in research and therapy.
    • Engineering chimeric proteins requires maintaining the functional integrity of complex molecular domains.
    • Previous methods faced challenges in preserving the activity of fused effector molecules.

    Purpose of the Study:

    • To develop and validate a method for constructing bifunctional, antibody-targeted chimeric proteins.
    • To demonstrate the feasibility of fusing complex effector molecules, such as tissue plasminogen activator (t-PA), to antibodies.
    • To assess the functional activity, specificity, and secretion of the resulting antibody-t-PA fusion protein.

    Main Methods:

    Related Experiment Videos

    • Construction of a chimeric protein by fusing an antifibrin antibody with tissue plasminogen activator (t-PA).
    • Utilized heavy chain loss variant cell lines and hybridoma technology for protein expression.
    • Characterized the secreted fusion protein using electrophoretic transfer blotting and functional assays for enzymatic activity and substrate specificity.

    Main Results:

    • Successfully generated a functional antibody-t-PA chimeric protein that retained enzymatic activity and substrate specificity.
    • The heavy chain-t-PA fusion protein was secreted as a 180-kDa dimer associated with the light chain, linked by disulfide bonds.
    • Demonstrated that complex molecules with stringent folding requirements can be incorporated into hybrid recombinant proteins.

    Conclusions:

    • The developed method is adaptable for creating various bifunctional, antibody-targeted proteins.
    • This approach allows for the precise targeting of diverse molecules for scientific investigation and medical therapy.
    • Future applications include minimizing immunogenicity through humanization and utilizing smaller antibody fragments like Fv.